Spreading depression (SD) known by transient loss of spontaneous and evoked neuronal activity and changes in ionic, metabolic and hemodynamic characteristics of the brain. Neuronal damage followed by SD, supposed to have a dramatic impression on SDderived pathologic conditions. We aimed to determine whether SD is able to stimulate persistent neurogenesis.
Spreading depression (SD) known by transient loss of spontaneous and evoked neuronal activity and changes in ionic, metabolic and hemodynamic characteristics of the brain. Neuronal damage followed by SD, supposed to have a dramatic impression on SDderived pathologic conditions. We aimed to determine whether SD is able to stimulate persistent neurogenesis.
Wistar rat (60-80 g) randomly chosen and 3 mol/L KCl injected for induction of SD. Four weeks after the first injection, all rats were decapitated and the brains removed. The density of mitotic cells, divided cells, and new neurons in the pyramidal cell layer of hippocampal CA1 and CA3 and granular cell layer of dentate gyrus was assessed. We also detect the DNA during the S phase using Bromodeoxyuridine (BrdU).
A remarkable increase occurred in the number of BrdU-labeled cells in hippocampal region, detected by immunohistochemistry method. The density of mitotic cells, divided cells, and new neurons in hippocampal CA1 and CA3 and granular cell layer of dentate gyrus also increased.
We conclude that Spreading depression potentiates to trigger persistent neurogenesis in rat hippocampus. Introduction: Neuroinflammation in utero may result in lifelong neurological deficits with microglia thought to play a key role. Double-hit experimental models of neuroinflammation are needed. We aimed to develop an in vivo -in vitro exposure model of neuroinflammation.
Methods: Near-term ovine fetuses were surgically instrumented with arterial and venous catheters. At 0.89 gestation (∼35 weeks in humans), animals received either lipopolysaccharide (LPS group, n = 12) or saline (Control, n = 9) intravenously on experimental days 1 and 2. Fetal arterial blood samples were taken at baseline and selected time points post LPS for plasma cytokines ELISA (IL-1beta and IL-6). At 54 hours, the animals were euthanized. Brains from instrumented fetuses and twins (controls) were perfusion-fixed for immunohistochemical analysis of regional microglia counts. In addition, two cell cultures were derived from brains of in vivo LPS exposed group and six cultures from brains of in vivo controls. Microglia were cultured for 6 h with or without LPS. Microglia purity was verified immunocytochemically and by flow cytometry. Cell conditioned media were collected and IL-1beta was measured (ELISA). Results were considered significant if P < 0.05.
Results: In vivo, IL-6, but not IL-1beta, peaked at 3 hours and declined to basal levels at 24 hours after the first LPS injection, with no further increase in IL-6 after the second LPS injection. LPS group showed higher regional microglia counts vs. controls. In vitro, at baseline, microglia secreted more IL-1beta in the in vivo LPS group than in Controls. LPS re-exposure further increased IL-1beta versus baseline. The relative IL-1beta increase was ∼4.6-fold in both cases.
Discussion: Inflammatory microglial phenotype acquired during in vivo exposure to LPS is sustained and potentiated in vitro upon re-exposure to LPS. This model allows studying mechanisms of fetal neuroinflammation in utero and in vitro to identify potential therapeutic targets for early postnatal intervention. 
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